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Abstract. Epidemiological studies indicate that the incidence of Alzheimer’s disease (AD) is higher in women than in men. There
is evidence that changes in metabolites in the brain associated with the development of AD are present earlier than structural
brain changes. The effect of sex on the metabolic profile during the development of AD has not yet been studied. In this study
we longitudinally monitored and compared in vivo metabolic changes in male and female APPswe, PSEN1dE9 transgenic
mice brains using magnetic resonance spectroscopy. Our results show a lower level of glutamate as well as of N-acetylaspartate
(NAA) in transgenic mice. The decline in NAA with age was more apparent in female mice. The level of taurine was higher in
female mice and showed a faster decline over time. In conclusion, our study is the first to suggest that changes in the metabolic
profile during AD development are influenced by sex.
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sex differences
INTRODUCTION
Alzheimer’s disease (AD) is a neurodegenerative
disease that causes dementia and is an increasing health
problem in the aging population; worldwide around 25
million people have AD and in 20 years this number
will be doubled [1]. AD is associated with amyloid-
 (A) plaque formation, neurofibrillary tangles, and
cerebral cortical atrophy, mainly found in the hip-
pocampus and the cerebral cortex [2]. There are strong
indications that the clinical symptoms of AD start
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years after the onset of plaque formation [3]. Currently,
AD can be diagnosed using a cognitive test combined
with a magnetic resonance imaging (MRI) scan of the
brain to detect cerebral atrophy and by determining the
amount of A and tau in the cerebrospinal fluid, but
not with complete accuracy [4]. Dementia and cere-
bral atrophy are very late stages of AD; therefore,
drugs that are able to modify the disease process can
only be expected to have little effect. If patients could
be diagnosed at the onset of neurodegeneration, when
symptoms are absent or subtle, the therapeutic window
for disease modifying drugs would be much wider and
there would be an increased expected gain. Therefore,
a more accurate and earlier diagnosis of AD is of vital
importance.
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It is known that females are at higher risk for devel-
oping AD than men [5, 6]. The effect of the mentioned
sex differences on the pathophysiology of AD has not
yet been carefully examined. Hormonal influences
have been suggested [7], however, the underlying
pathways accounting for the sex-related differences
remain unknown. One way to examine the metabolic
pathways non-invasively during early phases of AD,
and to study the influence of sex differences on these
metabolic pathways, is by focusing on the metabolic
changes in a transgenic (Tg) mouse model, by means
of magnetic resonance spectroscopy (MRS). MRS
is a noninvasive tool which can be used to measure
the concentration of various brain metabolites in vivo
[8]. Measuring these metabolic changes in vivo, using
MRS, could help identify AD at an early stage, prior
to the onset of cognitive symptoms [3]. Furthermore,
changes in metabolic profiles could provide superior
insight in the sex-related pathophysiologic mechanism
of the disease.
Several Tg mouse models are available that develop
pathology similar, however, not identical to human
AD. These Tg mouse models allow monitoring of
the metabolic changes from the onset of AD, which
is not detectable in patients. In the present study,
the APPswe,PSEN1dE9 mouse model is used. This
mouse model demonstrates many of the cognitive [9]
and neuropathological features of human AD, includ-
ing plaque development. These mice develop plaques
at 6 months of age and show decreased performance
of exploratory activity and spatial learning tests at 12
months of age [9]. In reproductive phenotype, no differ-
ences are found between this mouse model and control
mice. Studies using this mouse model have mainly
focused on histological data, including staining for A,
iron, and glial cells [10–16]. Among these histological
studies, no sex-related differences were reported. How-
ever, in other AD mouse models, a sex-related differ-
ence was found, showing more A in female mice [17,
18]. For glial cells, no sex difference was found yet.
Numerous MRS studies have been performed using
Tg mouse models of AD. However, until now, the
effect of sex on AD-related metabolic changes has
not been studied. The results of previous MRS stud-
ies have shown AD-related abnormalities for several
metabolites [11, 16, 19–25]. N-acetylaspartate (NAA)
in the brain is present predominantly in neuronal cell
bodies. Decreased NAA levels, indicating neuronal
damage, have been found in Tg mice in compari-
son to wild type (wt) mice [11, 20–24]. Myo inositol
(mIns) and taurine play a role in osmoregulation and
are mainly found in astrocytes of brain tissue. These
metabolites were found to be higher in Tg mice than in
wt mice [11, 19–22]. Glutamate (glu) is an excitatory
neurotransmitter, involved in learning, memory forma-
tion, and cognition, which is found to be decreased in
mice with AD [20–25]. Whether the changes in these
metabolites during AD progression are sex specific,
and whether they correlate temporally with timing of
plaque deposition in male and female mice, remained
to be investigated.
In this paper, we present the first systematic lon-
gitudinal MRS study to investigate the sex-related
differences in metabolic changes during development
of AD in the APPswe, PSEN1dE9 mouse model.
The main findings of this study were the differences
between male and female mice in NAA, taurine, and
histological data. These results suggest that changes
in the metabolic profile during AD development are
clearly influenced by sex. Based on this, future MRS
studies should consider specifying sex of the mice used
and analyzing the data for both sexes separately.
MATERIAL AND METHODS
Mice
In this study, 20 APP/PS1 Tg mice (12 male,
8 female); B6C3-Tg (APPswe, PSEN1dE9)
85Dbo/Jtg/0 from the Jackson Laboratory (Bar
Harbor, ME, USA) and 20 wt littermates (7 male, 13
female) were used. Ten Tg mice and wt mice were
followed for 18 months and scanned every 3 months
(time points: 3, 6, 9, 12, 15, and 18 months). For
each time point, following MRI, two Tg and two wt
mice of the remaining 10 Tg and 10 wt mice were
sacrificed for histological analysis; at time point 18
months, the mice used for the longitudinal study
were sacrificed. The Institutional Animal Care and
Animal Use Committee approved all the experiments
in accordance with the NIH guide for the care and use
of Laboratory animals. The mice were kept in a 12 h
light/dark circle.
Magnetic resonance spectroscopy
All measurements were conducted at 25◦C on
a vertical wide-bore 9.4T Bruker Avance 400WB
spectrometer, with a 1000 mTm-1 actively shielded
imaging gradient insert (Bruker BioSpin, Ettlingen,
Germany). The RF coil used was a 25 mm volume
RF coil, specifically, a birdcage transmit/receive coil
(Bruker BioSpin, Ettlingen, Germany). The system
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was interfaced to a Linux pc running Topspin 2.0 and
Paravision 5.0 imaging software (Bruker BioSpin).
Mice were anesthetized for in vivo MRS measure-
ments using isoflurane (Forene, Abott, UK), inhalation
anesthesia, in addition with air and oxygen (1 : 1) at 0.2
liter/min. The anesthetic gas was administered via a
special facemask, which also served as a fixation device
for the mouse head since it was coupled to a specially
designed toothbar to hold the head in place (Bruker
Biospin GmbH, Germany). The respiration rate of
the mouse inside the probe was constantly monitored
using a pressure transducer placed on the abdomen.
The transducer was connected to a BioTrig acquisition
module, which was interfaced to a BioTrig command
module and laptop running BioTrig BT1 monitoring
software (Bruker Biospin GmbH, Germany).
Localized T2-weighted multislice RARE images
were acquired to select a volume of interest [25]. The
MRS voxels were localized in the cortex-hippocampus
regions in the mouse brain (1.8 × 3.5 × 3.5 mm3;
22 l) (Fig. 1). The localized homogeneity was opti-
mized by adjustment of first- and second-order shim
coil currents using the FASTMAP sequence [26]. The
field homogeneity in a 22 l voxel typically resulted
in water line-widths of 20–25 Hz.
The PRESS (Point Resolved Spectroscopy)
sequence [27] was used for 1D localized 1 H MR
spectroscopy. This sequence uses 3 hermite RF pulses
(90◦, 180◦, and 180◦). The sequence details are
described by Mandal et al. [28]. The repetition time
and echo time were 1500 ms and 15 ms, respectively.
The PRESS sequence used 2048 complex points,
with a spectral width of 10 ppm. The final 1D spectra
were obtained with number of scans of 256 and
scan times of approximately 15 min. The 1D PRESS
sequences were preceded by a VAPOR sequence [29]
for global water suppression. The sequence consists
of 7 variable power RF pulses with an optimized
relaxation delay. The relaxation delays τ1-τ7- between
the consecutive pulses were 150, 80, 160, 80, 100,
37.11, and 57.36 ms. Water suppression bandwidth
was set at 350 Hz. Outer volume suppression (OVS)
was combined in an interleaved mode with a water
suppression scheme. This improves the localization
performance and reduces the demands for spoiler gra-
dients. The OVS scheme used a total of 18 hyperbolic
secant RF pulses, each with 90◦ nominal flip angle
and 1 ms pulse length. The OVS slice thickness was
4 mm with a 0 mm gap to the voxel.
The acquired in vivo 1D MR spectra were ana-
lyzed using LCModel [30]. This calculates the best
fit of the experimental spectrum based on a linear
combination of model spectra. The final analysis was
performed in the frequency domain; however, raw data
(FIDS) was used as standard data input. The follow-
ing metabolites were included in the basis set for
LCModel: alanine (Ala), aspartate (Asp), creatine (Cr),
-aminobutyric acid (GABA), glucose (Glc), gluta-
mate (Glu), glutamine (Gln), glycerophosphocholine
(GPC), choline (cho), phosphocholine (PCho), myo-
inositol (Ins), lactate (Lac), N-acetylacetate (NAA),
N-acetylaspartylglutamate (NAAG), phosphocreatine
(PCr), phosphoethanolamine (PE), scyllo-inositol
(sIns), and taurine. Quantification was obtained using
the tCr resonance as an internal standard, in our study
no difference was found in creatine. The LCModel fit-
ting was performed over the spectral range from 0.2 to
4.2 ppm. Signal to Noise ratio was above 5 and a %SD
of 20 or lower.
Fig. 1. Representative MR image and spectrum of the mouse
brain. A) A coronal MR image of the mouse brain, obtained
using RARE sequence, showing the position of the selected
22 l (1.8 × 3.5 × 3.5 mm3) voxel covering the cortex-hippocampus
region. B) One dimensional localized 1H-MR spectrum obtained
from the selected 22 l voxel placed in the brain of a 15-month old
control mouse. Spectrum was obtained using a PRESS sequence
with TR = 1500 ms and TE = 15 ms at 9.4T.
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Histology
Following in vivo MRS measurements, 2 wt and 2 Tg
mice were sacrificed at each time point, and their brains
were fixed in 4% buffered formaldehyde. Following
fixation, the brain was dehydrated and embedded in
paraffin, after which coronal sections (8 m thick)
were carefully cut using a microtome. To detect the
A plaques, brain sections were pretreated for 1 h with
70% formic acid followed by treatment with trypsin for
30 min at 37◦C. Subsequently sections were washed
in PBS and subjected to immunohistochemistry using
the primary antibody polyclonal anti-amyloid 40–42
antibody at 1 : 1000 (Alpha Diagnostics International,
San Antonio, USA) overnight followed by a sec-
ondary antibody swine anti-rabbit (Dako) 1 : 600 for
1 h. After washing 3 times with PBS, immunolabeling
was followed using a ABC kit (Vectastain) accord-
ing to the manufacturer’s instructions and visualized
with DAB (3,3′ diaminobenzidine, Sigma). Detection
of iron was done by a DAB-enhanced Perl’s staining
according to Smith et al. [31]. To stain glial cells, a
primary polyclonal anti-GFAP (glial fibrillary acidic
protein) antibody (Dako) was used following stan-
dard procedure. To detect the activated microglia and
macrophages, a primary polyclonal anti-IBA1 (ionized
calcium binding adaptor molecule 1) antibody 1 : 1000
(Wako Chemicals, Neuss, Germany) was used. Prior
to the IBA-1 antibody, a pretreatment with trypsin was
performed for 30 min at 37ºC. Since the plaque devel-
opment in APPswe, PSEN1dE9 Tg mouse starts at
approximately 6 months of age, the histological data
in male and female mice are shown at the age of 3, 6,
and 9 months.
Histological images were acquired using a
panoramic midi scanner (3D Histech, Budapest,
Hungary). For quantitative histological analysis,
regions of interest (ROIs) were selected in the cortex
and hippocampus and the area percentage of stained
tissue was calculated in these ROIs using ImageJ
software (ImageJ, USA). The colors were unmixed
using the plug-in color deconvolution, the stained area
was selected, and the percentage of the total area was
calculated using analyze particles.
Statistical analysis
To investigate significant age-related differences
between either sex or Tg and controls, a mixed model
analysis was performed including scatter plots using
SPSS software (version 17.0; SPSS, Inc., Chicago,
IL). Mean differences were compared using one way




Of all metabolites measured only glu, NAA, tau, and
mIns are presented because they show either statistical
significant results or a trend.
As shown in Fig. 2A, the glutamate (glu)/Cr ratio
was lower in Tg mice compared to wt mice at all ages
(Fig. 2A; Tables 1 and 2), and the rate of decline in
glu/Cr ratio with age was more pronounced in Tg mice
than in wt mice. A sex difference in the level and rate
of decline in glutamate became apparent after sepa-
ration of the data of male and female mice. In male
wt mice, the glu/Cr ratio decreased over time, in con-
trast to wt female mice, in which it slightly increased.
However, in Tg mice, the glu/Cr ratio decreased in
both male and female. At 18 months, a significant dif-
ference (p < 0.05) is found between wt male (0.84) and
wt female (0.97) mice, and between Tg male (0.87)
and Tg female (0.94) mice (Tables 1 and 2).
The NAA/Cr ratio was higher in wt mice in com-
parison to Tg mice (Fig. 2B; Tables 1 and 2) and
decreased over time in both wt and in Tg mice. Overall
the NAA/Cr ratio was higher in female when compared
to male in both wt and Tg mice. In female mice a faster
decrease in NAA/Cr ratio was observed in Tg than in
wt mice leading to a more apparent difference at 18
months of age than in males. Female Tg mice showed
a faster decline than male Tg mice (Fig. 2B (b,c)).
When male and female mice were taken together,
the ratio of taurine/Cr was similar for Tg and wt mice
at all time points (Fig. 2D; Tables 1 and 2). Male wt
and Tg mice showed a comparable taurine/Cr ratio at
3 months and a similar decrease over time. Female Tg
mice showed a much stronger decline compared with
male Tg and female wt mice. The taurine/Cr ratio in
female Tg mice started higher at 3 months and ended
lower at 18 months than in male Tg, female wt, and
male wt mice.
In Tg mice, the mIns/Cr ratio started lower than in
the wt mice and increased over time while this ratio
slightly decreased in wt mice (Fig. 2C; Tables 1 and 2).
Separating male and female mice showed comparable
results.
Histology
Figure 4 shows the results of A in the brain sections
of 6 and 9 month old male Tg and female Tg mice. The





Fig. 2. Longitudinal monitoring of sex-related differences in (A) glutamate (glu)/creatine (Cr) ratio, (B) N-acetylaspartate (NAA)/Cr ratio, (C)
Tau/Cr ratio, and (D) Myo inositol (mIns)/Cr ratio in the cortex-hippocampus regions of all mice, male and female mouse brain measured using
in vivo MRS at 9.4T.
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Table 1
R2 of the linear regression line of the metabolic changes over time
in wild type (WT) and transgenic (TG) mice. The differences are
shown in male (M) and female (F) for glutamate, N-acetylaspartate
(NAA), taurine, and myo inositol
R2 Glutamate NAA Taurine Myo inositol
WT 0.00 0.21 0.20 0.00
TG 0.01 0.14 0.19 0.02
M WT 0.07 0.26 0.22 0.04
M TG 0.01 0.08 0.08 0.01
F WT 0.01 0.18 0.29 0.00
F TG 0.01 0.29 0.54 0.05
A deposition in the brain increased more rapidly in
Tg female mice than in Tg male mice (Fig. 4A). Iron
deposition showed the same pattern as A deposition.
No A or iron deposition was found in wt mice, even
at 9 months.
This difference between male and female was more
prominent in the cortex than in the hippocampus
(Figs. 3 and 4).
Quantification of the amount of GFAP and IBA-1
showed no difference between wt and Tg mice. How-
ever, in the Tg mouse brain the distribution of both
GFAP and IBA-1 became irregular over time, because
GFAP and IBA-1 positive cells aggregate around
plaques (Fig. 4B, C). In wt mice, the deposition of
GFAP and IBA-1 was more evenly distributed than in
Tg mice (Fig. 4B, C). The presence of these plaque
associated GFAP depositions was visible earlier in
female brain than in male brain (Fig. 4B).
DISCUSSION
This is the first longitudinal study showing that
changes in metabolic profile during AD development
Table 2
Mean ratio of glutamate, N-acetylaspartate (NAA), taurine, and Myo inositol with respect to creatine in 3 and 18 months old wild type (wt) and
transgenic (Tg) mice (mean ± standard deviation). Wt and Tg were separated in male (M) and female (F)
Glutamate NAA Taurine Myo inositol
3 months 18 months 3 months 18 months 3 months 18 months 3 months 18 months
WT 0.97 ± 0.05 0.93 ± 0.07 1.01 ± 0.08 0.87 ± 0.35 0.58 ± 0.04 0.47 ± 0.09 0.79 ± 0.11 0.79 ± 0.83
TG 0.93 ± 0.08 0.90 ± 0.05 0.95 ± 0.01 0.87 ± 0.04 0.59 ± 0.07 0.44 ± 0.17 0.73 ± 0.02 0.75 ± 0.06
M wt 0.91 0.84 ± 0.01* 0.97 0.86 ± 0.01 0.57 0.55 ± 0.02 0.70 0.76
M Tg 0.91 ± 0.07 0.87 ± 0.04* 0.94 ± 0.11 0.86 ± 0.03 0.54 ± 0.03 0.48 ± 0.23 0.74 ± 0.01 0.71 ± 0.07
F wt 0.98 ± 0.04 0.97 ± 0.05* 1.03 ± 0.09 0.88 ± 0.04 0.58 ± 0.05 0.45 ± 0.09 0.81 ± 0.11 0.80 ± 0.09
F Tg 0.95 ± 0.11 0.94 ± 0.02* 0.97 ± 0.13 0.87 ± 0.06 0.66 ± 0.01 0.39 ± 0.17 0.70 0.79 ± 0.03
*Difference between male and female mice at 18 months for glutamate was significant (p < 0.05) for both wt and Tg
Fig. 3. Quantitative analysis of sex-related differences in A (A) and iron (B) deposition in wt and tg mouse brain. a) Surface percentage (%) of
deposition in the cortex of wt and Tg mice; (b) % of deposition in the cortex of male and female Tg mice; (c) % of deposition in the hippocampus
of wt and Tg mice; (d) % of deposition in the hippocampus of male and female Tg mice. Percentage of A and iron deposition in the cortex and
hippocampus elevate during the development of AD in Tg mice. The elevation starts earlier in female mice as compared to male mice.
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Fig. 4. A staining (A), GFAP staining (B), and IBA-1 staining (C) in brain sections of 6 month (6 mo) and 9 month (9 mo) old transgenic male
and female mice. Magnified area of (1) cortex (scale bar, 200 m) and (2) hippocampus (scale bar, 500 m) is shown. Arrows indicate immune
stained A plaques, GFAP depositions, and IBA-1 depositions.
are influenced by sex in a mouse model of AD. The
main findings of this study are: 1) female mice have
increased plaque development as well as increased
activation of microglia surrounding the plaques com-
pared with male mice; and 2) the decline in NAA and
taurine during AD development is more apparent in
female Tg mice than in male Tg mice in both the cor-
tex and hippocampus. Most of these differences are
statistically not significant, probably due to the low
number of mice and lower inter individual variability
at the different time points, but a trend is apparent. We
tried to limit inter individual variability by scanning
the wt and Tg mice for each time point at the same
day with the same protocol. Instrumental limitations
were excluded as far as possible by doing phantom
studies, being preparations with known amounts of
metabolites.
One lesson we learned from our study is that sex-
specific differences between animals can influence
study results. Comparison of wt and Tg mice show
different results than comparison of the individual
male and female subpopulation. For instance, the dif-
ference in NAA/Cr ratio between female wt and Tg
mice increases over time, while for male Tg and
wt mice, the difference in NAA/Cr ratio decreases.
This may explain why the results, as presented in our
study, differ at some parameters from earlier studies
[11, 22, 23, 25].
We observed an increase of the glu/Cr ratio in female
wt mice and a decrease in male wt mice over time,
which indicates that the glu/Cr ratio between wt and Tg
is sex dependent. In several earlier studies glu/Cr ratio
changes were observed, but the sex of the studied mice
was not mentioned or sex was not taken into account
in the analysis of the data [11, 21, 22, 24].
In a previous study [22], mIns was increased in
Tg mice compared with wt mice, however male and
female mice in the Tg group were presented together,
while only female wt mice were used, which means
the two groups could in fact not be compared due to
the sex differences. Chen et al. [11] found no signif-
icant differences between male and female and this
study confirmed the differences between Tg and wt
mice found by Marjanska et al. [22].
The ratio of taurine/Cr was higher in female Tg mice
than in wt mice at an early age (3 and 6 month) but at
9 months the taurine/Cr ratio was lower in female Tg
mice. However, the mIns/Cr ratio started slightly lower
in the Tg mice than in the wt mice (3 and 6 months),
but, at 12 month the ratio of mIns/Cr was higher in
the Tg mice than in the wt mice. Myo inositol and
taurine are known to be involved in osmotic regulation
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across the cellular membrane and are mostly present
in glial cells [22]. Despite these functional similarities,
our results indicate that in Tg mice the two metabolites
show an opposite trend; mIns slightly increases with
age (as opposed to a stable amount in wt) and taurine
decreases with age (more than the decrease in wt).
Our histological data show an increase in plaque
deposition in Tg mice which was correlated with an
increase in iron as well as an increase of GFAP posi-
tive glial cells around plaques with age. This increase
was more apparent in the female mice. Previous his-
tological studies in APP/PS1 mice have shown an
increase in plaque deposition after 3 to 5 months. In
addition, an increase in GFAP positive glial cells is
reported in these mice at 5–8 months [11, 14, 15, 32].
However, these studies did not show sex differences in
deposition of plaque, iron, or GFAP.
Although the pattern of GFAP positive cells changes
while plaques develop in the brain, the overall den-
sity of these cells is not clearly different between wt
and Tg brain tissue. This is reflected by the minimal
increase of myo inositol and even a decrease of taurine,
both osmoregulatory proteins, which are particularly
present in glial cells.
The increased level of the NAA/Cr ratio in the
female brain, for both wt and Tg mice, can be explained
by the fact that females seem to have a higher cere-
bral axonal density than males [33]. The mechanisms
responsible for the sex differences in A and iron depo-
sition are not yet known.
Our study is the first study to systematically investi-
gate the influence of sex on metabolic and histological
changes in AD over time using an AD mouse model.
The use of a mouse model allows examining early
changes in AD, which is not possible in humans.
Our findings show for the first time that changes in
metabolic profile during AD development is influenced
by sex. These results are in line with the known higher
risk of AD in women [5, 6]. The area of sex differ-
ences in AD is still largely unexplored but knowledge
of metabolic differences would offer great promise
for diagnosis and for the future development of better
strategies for intervention in patients.
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